Acetylcholinesterase (AChE) has rekindled attention as a therapeutic target in Alzheimer's disease (AD) because it improves brain cell function by boosting acetylcholine concentrations8. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.